Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques-Eric Gottenberg

Showing results (151-160 of 311) with videos related to

Pageof 32
Sort By:
Rheumatology (Oxford, England)|May 14, 2014
Influence of gender on response to rituximab in patients with rheumatoid arthritis: results from the Autoimmunity and Rituximab registryMarion Couderc, Jacques-Eric Gottenberg, Xavier Mariette, et al.
Rheumatology and Therapy|September 14, 2021
Identification of a Rule to Predict Response to Sarilumab in Patients with Rheumatoid Arthritis Using Machine Learning and Clinical Trial DataMarkus Rehberg, Clemens Giegerich, Amy Praestgaard, et al.
Arthritis Care & Research|October 10, 2014
Efficacy and safety of rituximab in elderly patients with rheumatoid arthritis enrolled in a French Society of Rheumatology registrySarah Payet, Martin Soubrier, Elodie Perrodeau, et al.
NPJ Systems Biology and Applications|March 28, 2026
The SjD Map: an interactive pathway tour into Sjögren's disease signalling mechanismsSacha E Silva-Saffar, Xavier Mariette, Jacques-Eric Gottenberg, et al.
Journal of Autoimmunity|January 14, 2014
Differentiation of follicular helper T cells by salivary gland epithelial cells in primary Sjögren's syndromeYa-Zhuo Gong, Joanne Nititham, Kim Taylor, et al.
Seminars in Arthritis and Rheumatism|July 15, 2019
T1 mapping cardiac magnetic resonance imaging frequently detects subclinical diffuse myocardial fibrosis in systemic sclerosis patientsVincent Poindron, Emmanuel Chatelus, Matthieu Canuet, et al.
Annals of the Rheumatic Diseases|November 6, 2021
Integrated safety analysis of filgotinib in patients with moderately to severely active rheumatoid arthritis receiving treatment over a median of 1.6 yearsKevin L Winthrop, Yoshiya Tanaka, Tsutomu Takeuchi, et al.
JAMA|July 24, 2019
Effect of Filgotinib vs Placebo on Clinical Response in Patients With Moderate to Severe Rheumatoid Arthritis Refractory to Disease-Modifying Antirheumatic Drug Therapy: The FINCH 2 Randomized Clinical TrialMark C Genovese, Kenneth Kalunian, Jacques-Eric Gottenberg, et al.
The Journal of Rheumatology|November 5, 2013
Rheumatic and musculoskeletal features of Whipple disease: a report of 29 casesMarine Meunier, Xavier Puechal, Emmanuel Hoppé, et al.
The Journal of Biological Chemistry|July 25, 2016
Antibodies That Block or Activate Mouse B Cell Activating Factor of the Tumor Necrosis Factor (TNF) Family (BAFF), Respectively, Induce B Cell Depletion or B Cell HyperplasiaChristine Kowalczyk-Quintas, Sonia Schuepbach-Mallepell, Michele Vigolo, et al.
Pageof 32

Showing results (151-160 of 311) with videos related to

Sort By:
Pageof 32
Rheumatology (Oxford, England)|May 14, 2014
Influence of gender on response to rituximab in patients with rheumatoid arthritis: results from the Autoimmunity and Rituximab registryMarion Couderc, Jacques-Eric Gottenberg, Xavier Mariette, et al.
Rheumatology and Therapy|September 14, 2021
Identification of a Rule to Predict Response to Sarilumab in Patients with Rheumatoid Arthritis Using Machine Learning and Clinical Trial DataMarkus Rehberg, Clemens Giegerich, Amy Praestgaard, et al.
Arthritis Care & Research|October 10, 2014
Efficacy and safety of rituximab in elderly patients with rheumatoid arthritis enrolled in a French Society of Rheumatology registrySarah Payet, Martin Soubrier, Elodie Perrodeau, et al.
NPJ Systems Biology and Applications|March 28, 2026
The SjD Map: an interactive pathway tour into Sjögren's disease signalling mechanismsSacha E Silva-Saffar, Xavier Mariette, Jacques-Eric Gottenberg, et al.
Journal of Autoimmunity|January 14, 2014
Differentiation of follicular helper T cells by salivary gland epithelial cells in primary Sjögren's syndromeYa-Zhuo Gong, Joanne Nititham, Kim Taylor, et al.
Seminars in Arthritis and Rheumatism|July 15, 2019
T1 mapping cardiac magnetic resonance imaging frequently detects subclinical diffuse myocardial fibrosis in systemic sclerosis patientsVincent Poindron, Emmanuel Chatelus, Matthieu Canuet, et al.
Annals of the Rheumatic Diseases|November 6, 2021
Integrated safety analysis of filgotinib in patients with moderately to severely active rheumatoid arthritis receiving treatment over a median of 1.6 yearsKevin L Winthrop, Yoshiya Tanaka, Tsutomu Takeuchi, et al.
JAMA|July 24, 2019
Effect of Filgotinib vs Placebo on Clinical Response in Patients With Moderate to Severe Rheumatoid Arthritis Refractory to Disease-Modifying Antirheumatic Drug Therapy: The FINCH 2 Randomized Clinical TrialMark C Genovese, Kenneth Kalunian, Jacques-Eric Gottenberg, et al.
The Journal of Rheumatology|November 5, 2013
Rheumatic and musculoskeletal features of Whipple disease: a report of 29 casesMarine Meunier, Xavier Puechal, Emmanuel Hoppé, et al.
The Journal of Biological Chemistry|July 25, 2016
Antibodies That Block or Activate Mouse B Cell Activating Factor of the Tumor Necrosis Factor (TNF) Family (BAFF), Respectively, Induce B Cell Depletion or B Cell HyperplasiaChristine Kowalczyk-Quintas, Sonia Schuepbach-Mallepell, Michele Vigolo, et al.
Pageof 32